Article
11 November 2025 - by Claire Booth, David Burston, Monique Mahabir, Chew Hou Ng, Subadra Raman, Stuart Reynolds, Isabel Stansfield, Kelly Yang
We review the value and capital generation metrics for Solvency II, Solvency UK and Swiss Solvency Test as of year-end 2024.
Article
15 May 2025 - by Ian Humphries, Katie Nelson, Tanner McKerlie, Chew Hou Ng, Sam Burgess, Stuart Reynolds, Ariel Hojman, Fernando Mesquida, Richard Taylor, David Kirk, Su Meng Lee
A review of 2024 and an outlook for 2025 and beyond, covering transactions in North America, Europe, Asia, Latin America, and Africa.
Article
16 September 2024 - by Sam Burgess, David Burston, Tatiana Egoshina, Andrew Kirk, Chew Hou Ng, Stuart Reynolds, Isabel Stansfield, Lyndsay Wrobel
Our 2024 annual summary of Solvency II-based metrics details last year’s results and gives insight on key themes in reporting.
Article
16 April 2024 - by Ian Humphries, Katie Nelson, Tanner McKerlie, Chew Hou Ng, Sam Burgess, Lyndsay Wrobel, Stuart Reynolds, Ariel Hojman, Fernando Mesquida
Globally, 80 life and health insurance mergers and acquisitions were announced in 2023, down from 131 in 2022. However, total publicly announced deal values rose from US$20.4 billion in 2022 to US$21.5 billion in 2023.
Article
13 November 2023 - by Sam Burgess, Tatiana Egoshina, Stuart Reynolds, Isabel Stansfield, Lyndsay Wrobel
This report summarises the annual research performed by Milliman which looks at Solvency II based metrics for a sample of over 20 firms in Europe based on disclosures at year-end 2022.
Article
03 August 2023 - by Ian Humphries, Sam Burgess, Katie Nelson, Tubin Wang, Candace Wang, John Gakuya, Stuart Reynolds
In 2022, life and health insurance transaction activity was down sharply. Our research points to the likely causes and projects the landscape for future mergers and acquisitions.
Article
21 March 2023 - by Sam Burgess, Stuart Reynolds, Lyndsay Wrobel
We consider what key themes can be drawn from how European insurers have reported their performance over 2021 in a post-COVID environment.
Article
18 October 2022 - by Sam Burgess, Neil Christy, Stuart Reynolds, Isabel Stansfield
Our analysis covering Europe and the U.K. dives into SFCRs from year-end 2021, including key financial information contained in the reports’ QRTs.
Article
06 July 2022 - by David Burston, Jessica Hall, Stuart Reynolds, Isabel Stansfield
Despite its ease of calculation, capital generation and return—measured as a change in eligible own funds—may not be the most useful metric.
Article
30 November 2021 - by Sam Burgess, Stuart Reynolds, Lyndsay Wrobel
We consider the impact of the pandemic to firms’ supplementary reporting metrics, and their level of Solvency II Own Funds and solvency positions.